Nexalin Technology Inc.
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Genera… Read more
Nexalin Technology Inc. (NXL) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.307x
Based on the latest financial reports, Nexalin Technology Inc. (NXL) has a cash flow conversion efficiency ratio of -0.307x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.47 Million) by net assets ($4.77 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nexalin Technology Inc. - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Nexalin Technology Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Nexalin Technology Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nexalin Technology Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Viveon Health Acquisition Corp
NYSE MKT:VHAQ
|
0.000x |
|
Rand Capital Corp
NASDAQ:RAND
|
0.009x |
|
Athanase Innovation AB
ST:ATIN
|
-0.037x |
|
Patagonia Gold Corp
PINK:HGLD
|
-0.023x |
|
Chibougamau Independent Mines Inc
PINK:CMAUF
|
0.017x |
|
Landmarks Bhd
KLSE:1643
|
-0.009x |
|
Korfez Gayrimenkul Yatirim
IS:KRGYO
|
0.012x |
|
BIOMAXIMA SA ZY 1
F:944
|
N/A |
Annual Cash Flow Conversion Efficiency for Nexalin Technology Inc. (2019–2024)
The table below shows the annual cash flow conversion efficiency of Nexalin Technology Inc. from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $3.68 Million | $-3.94 Million | -1.073x | +10.29% |
| 2023-12-31 | $3.21 Million | $-3.84 Million | -1.196x | -195.75% |
| 2022-12-31 | $5.48 Million | $-2.22 Million | -0.404x | -163.17% |
| 2021-12-31 | $-1.68 Million | $-1.08 Million | 0.640x | +17.91% |
| 2020-12-31 | $-1.59 Million | $-863.47K | 0.543x | -5.60% |
| 2019-12-31 | $-1.18 Million | $-678.34K | 0.575x | -- |